Brown Advisory’s Procept Biorobotics PRCT Stock Holding History

Brown Advisory’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,240	Closed	-$513K	–	1283
2023 Q4	$513K	Sell	12,240 -8,184	-40%	-$279K	﹤0.01%	930
2023 Q3	$670K	Hold	20,424	–	–	﹤0.01%	836
2023 Q2	$722K	Hold	20,424	–	–	﹤0.01%	819
2023 Q1	$580K	Hold	20,424	–	–	﹤0.01%	883
2022 Q4	$848K	Sell	20,424 -10,500	-34%	-$451K	﹤0.01%	793
2022 Q3	$1.28M	Sell	30,924 -12,500	-29%	-$499K	﹤0.01%	658
2022 Q2	$1.42M	Sell	43,424 -11,400	-21%	-$415K	﹤0.01%	635
2022 Q1	$1.92M	Buy	+54,824	New	+$1.32M	﹤0.01%	587

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory's PRCT Position: Q1 2024 in Review

Brown Advisory sold out of Procept Biorobotics (PRCT) in Q1 2024, closing a stake of 12,240 shares — an estimated $513K sold.

Brown Advisory first reported a position in PRCT in Q1 2022 and held it in 8 quarters. The position peaked at $1.92M in Q1 2022. 162 funds tracked by Wall St. Rank hold PRCT as of Q1 2024.

Brown Advisory reported no remaining Procept Biorobotics position as of Q1 2024 after selling out during the quarter.
Brown Advisory sold 12,240 Procept Biorobotics shares in Q1 2024, an estimated $513K.
Brown Advisory first reported a position in Procept Biorobotics in Q1 2022 and held it in 8 quarters.
Brown Advisory's Procept Biorobotics position peaked at $1.92M in Q1 2022.
162 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2024.

Based on Brown Advisory's 13F filing for Q1 2024, filed 24 Apr 2024.